Valneva SE
VALN • Biotechnology
$5.69
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$465.50M
Growth
6.5%
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 2.38Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 13, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:53 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$5.69
Change0.00%
Shares Out86.04M
Market Cap$465.50M
52W Range4.75 - 12.25
Beta1.35
P/E-3.47
P/S14.42
P/B5.80
P/FCF-788.44
EV/Sales18.43
EV/EBITDA-21.78
Price$5.69
Change0.00%
Shares Out86.04M
Market Cap$465.50M
52W Range4.75 - 12.25
Beta1.35
P/E-3.47
P/S14.42
P/B5.80
P/FCF-788.44
EV/Sales18.43
EV/EBITDA-21.78
EV/FCF-1,008.11
Earnings Yield-7.20%
FCF Yield-0.13%
Dividend Yield0.00%
Gross Margin38.66%
Oper. Margin-46.74%
Profit Margin-65.95%
Debt/Eq1.95
Current Ratio2.38
Quick Ratio1.85
Revenue 5Y6.49%
Target$17.00
Target Upside198.77%
Target Median$14.00
Target Range11.00 - 26.00
Volume29.29K
Avg Volume29.61K
EPS Surprise-0.21
Investment DNA
How strong this company looks for long-term investors
35
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
58/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
64/100
Why this score▼
Healthy liquidity · 2.38Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 3 analyst votes · 2026-10-20
67/100
Neutral
Bullish
2
Hold
0
Bearish
1
Price Target
2026-08-14
Low
$11.00
Mean
$11.00
Median
$11.00
High
$11.00
🧾
No insider activity
No recent insider transactions available.